Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 22:12:365-372.
doi: 10.2147/DDDT.S156467. eCollection 2018.

Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis

Nongsak Chanasumon  1 , Tueboon Sriphojanart  1 , Poonkiat Suchonwanit  1
Affiliations
Review

Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis

Nongsak Chanasumon et al. Drug Des Devel Ther. .

Abstract

Eyebrows serve as a key feature of the face and have many roles, including cosmetic appearance and social communication. Eyebrow hypotrichosis, which refers to reduction or absence of the eyebrow hair, could be a major problem that leads to negative functional, psychological, and social consequences. Bimatoprost is an ophthalmic prostamide analog that is approved by the United States Food and Drug Administration for the treatment of eyelash hypotrichosis. Its proposed mechanism is stimulation of the prostaglandin receptor in dermal papilla and melanocyte, thus leading to a prolonged anagen phase and increased melanogenesis. The hair follicle then increases in thickness, length, and darkness. The efficacy of bimatoprost for the treatment of eyebrow hypotrichosis has been supported by well-controlled studies. Bimatoprost, which is noninvasive, effective, and well tolerated, is worth considering as a treatment option for eyebrow hypotrichosis.

Keywords: bimatoprost; eyebrow; hair; hypotrichosis; prostaglandin; prostamide.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
The algorithm reveals the clinical approach of eyebrow hypotrichosis. Abbreviations: AA, alopecia areata; AD, atopic dermatitis; AE, anagen effluvium; BCC, basal cell carcinoma; CTCL, cutaneous T-cell lymphoma; DLE, discoid lupus erythematosus; FFA, frontal fibrosing alopecia; MM, malignant melanoma; SCC, squamous cell carcinoma; SD, seborrheic dermatitis; TE, telogen effluvium; TTM, trichotillomania.
Figure 2
Figure 2
Chemical structure of bimatoprost.
See this image and copyright information in PMC

References

    1. Sadr J, Jarudi I, Sinha P. The role of eyebrows in face recognition. Perception. 2003;32:285–293. - PubMed
    1. Goldman GD. Eyebrow transplantation. Dermatol Surg. 2001;27:352–354. - PubMed
    1. Velez N, Khera P, English JC., 3rd Eyebrow loss: clinical review. Am J Clin Dermatol. 2007;8:337–346. - PubMed
    1. Cohen JL. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth. Dermatol Surg. 2010;36:1361–1371. - PubMed
    1. Margulis A, Amar D, Billig A, Adler N. Periorbital reconstruction with the expanded pedicled forehead flap. Ann Plast Surg. 2015;74:313–317. - PubMed

MeSH terms